San Francisco, California, January 30, 2018: TMR Research has published a new report titled, “Downstream Processing Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.” As per the report, the growth of the downstream processing market is primarily carried forward by the rise in demand for biopharmaceutical products. This is so because downstream processing has a vital part in lending out pure and quality biopharmaceutical products. The rising expenses on research and development of biopharmaceuticals is also leading to the growth of the downstream processing market.
However, factors like inefficient pricing as well as the lack of skilled personnel required in procuring instruments is restraining this markets from reaching it’s real potential. Plus, purification bottlenecks as well as the absence of single use options act as a hurdle in the expansion of the downstream processing market. Nevertheless, patent expiration of blockbuster biopharmaceuticals is predicted to bring in great opportunities for the expansion and growth of the downstream processing market.
The developing markets of Asia Pacific is predicted to offer new growth chances to the growth of the downstream processing market. The Global market for downstream processing is divided on the basis purification, technique, solid-liquid separation and clarification/concentration are the divisions into which the downstream processing market is divided. Among these, purification had the majority share in the recent past because of the growing need for biopharmaceutical products that comply with regulatory requirements. Thus, the need for downstream processing is growing for improving the purity as well as the quality of products, thus benefiting the purification part of the downstream processing market.
On the basis of product, this market is divided into chromatography columns and resins, membranes absorbers, filters, single use products, and other products. Chromatography columns and resins had the major market share in the last few years.
Mergers and acquisitions are the center of focus for major companies in bioprocessing industry for continuous growth. In a new industry development, Thermo Fisher said that it is buying Finesse solutions- the company which was providing measurement as well as control solutions for Thermo Fisher from a long time. After this deal, bioprocess management technology capabilities of Finesse Solutions would be added to Thermo Fisher’s life sciences division. As Finesse solutions was Thermo Fisher’s Technology partner in the last couple of years, the finesse solutions Universal control system along with Thermo Fisher’s single use technologies is predicted to make the position of Thermo Fisher stronger in the high growth bioproduction market.
One of the primary markets for downstream processing is the North America, as it held the majority share in the market in the last few years, because North America has the highest biopharmaceutical research and is the biggest market for pharmaceuticals in the world. Asia Pacific is predicted to showcase the best growth rate in the years to come. India, South Korea, China, Japan are projected as the main contributors to the Asia Pacific downstream processing market. Plus, factors like the considerable investments by big market players, emerging research and development infrastructure, growing government support.
Get Sample Copy of this Report